Open AccessReperfusion Therapy for ST-Elevation Myocardial Infarction at Dr. Soetomo General Academic Hospital Surabaya
Author(s) -
Rosavelina Sintaasih Budihardjo,
Agus Subagjo,
Subur Prajitno
Publication year - 2021
Publication title -
cardiovascular and cardiometabolic journal
Language(s) - English
Resource type - Journals
eISSN - 2746-6930
pISSN - 2722-3582
DOI - 10.20473/ccj.v2i1.2021.1-9
Subject(s) - medicine , conventional pci , referral , reperfusion therapy , myocardial infarction , door to balloon , general hospital , st segment , simple random sample , mortality rate , st elevation , emergency medicine , family medicine , population , environmental health , cath lab
Background: Cardiovascular disease is the number one cause of death in the world by killing 17,9 million people every year. The most frequent cardiovascular disease occurs as STEMI which related to the depiction of persistent depiction of EKG elevation with ST segment. This research is aiming for figure out the profile of reperfusion therapy at Dr. Soetomo General Academic Hospital, Surabaya. Methods: In this research, the data is collected using observation method, without any treatment applied with descriptive statistical analysis using table. The data collection techniques used is simple random sampling. Results: The STEMI patients at Dr. Soetomo General Academic Hospital Surabaya are dominated by referral patients (79,2%) from approximately 40 hospitals in East Java. Most of the patients were male, the ages between 51 – 60 years old with the most frequent risk factors was the combination of type 2 diabetes mellitus, hypertension, and smoking. The reperfusion therapy given was PCI with a door to balloon <120 minutes was 59.6%. Fibrinolytic that was done in <12 hours after onset was 82.9%. Patients with STEMI managed at Dr. Soetomo General Academic Hospital Surabaya, had mortality rates around 12.2%. Conclusion: Most of the STEMI patients in Dr. Sutomo General Academic Hospital Surabaya was a referral patient and had sufficiently good PCI and fibrinolytic reperfusion therapy, resulting in a low mortality rate.